Blood pressure and fluid retention drugs recalled over cancer concerns - SlashGear

The recall covers the pharmaceutical company’s Irbesartan Tablets USP in 75mg, 150mg, and 300mg strengths, as well as its Irbesartan and Hydrochlorothiazide Tablets USP in 150mg/12.5mg and 300mg/12.5mg strengths.

These medications are commonly prescribed to treat high blood pressure and fluid retention.

The products were sold in 30-count and 90-count bottles.